Accolade Inc. (ACCD)
undefined
undefined%
At close: undefined
3.50
0.00%
After-hours Jan 06, 2025, 05:40 PM EST

Company Description

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.

The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists.

It also provides second opinion consultation and health care decision support services.

The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs.

Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Accolade Inc.
Accolade Inc. logo
Country United States
IPO Date Jul 1, 2020
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 2,400
CEO Rajeev Singh

Contact Details

Address:
660 West Germantown Pike
Plymouth Meeting, Pennsylvania
United States
Website https://www.accolade.com

Stock Details

Ticker Symbol ACCD
Exchange NASDAQ
Fiscal Year March - February
Reporting Currency USD
CIK Code 0001481646
CUSIP Number 00437E102
ISIN Number US00437E1029
Employer ID 43-2117836
SIC Code 7389

Key Executives

Name Position
Rajeev Singh Chairman of the Board & Chief Executive Officer
Kelsi McDonald Harris Chief People Officer & Senior Vice President
Stephen H. Barnes CPA Chief Financial Officer & Treasurer
Colin McHugh Chief Accounting Officer
Dr. Shantanu Nundy M.B.A., M.D. Executive Vice President, Chief Health Officer & Member of the Medical Advisory Board
Drew Garner Executive Vice President of Engineering
Kristen Bruzek Senior Vice President of Operations
Richard Eskew J.D. Executive Vice President, General Counsel, CCO & Secretary
Robert Cavanaugh President
Todd Friedman Senior Vice President of Investor Relations

Latest SEC Filings

Date Type Title
Jan 06, 2025 4 Filing
Jan 06, 2025 4 Filing
Jan 06, 2025 4 Filing
Jan 06, 2025 4 Filing
Jan 06, 2025 4 Filing
Dec 18, 2024 4 Filing
Dec 18, 2024 4 Filing
Dec 18, 2024 4 Filing
Dec 18, 2024 4 Filing
Dec 12, 2024 4 Filing